Beta-Blockers Cause Lack Of Restful Sleep – Life Extension | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« One year Post-Intervention Mortality Rate: TAVR and AVR – Aortic Valve Procedures 6.7% in AVR, 11.0% in AVR with CABG, 20.7 in Transvascular (TV-TAVR) and 28.0% in Transapical (TA-TAVR) Patients

The ALLHAT: Thiazide diuretics as first-line antihypertensive therapy [Classics Series] | 2 Minute Medicine »

Beta-Blockers Cause Lack Of Restful Sleep – Life Extension

August 4, 2014 by 2012pharmaceutical

Beta-Blockers Cause Lack Of Restful Sleep – Life Extension

Reporter: Aviva Lev-Ari, PhD, RN

Beta-blockers to reduce blood pressure can lead to chronic sleep disturbances by blocking melatonin production. Melatonin may correct this common problem that is often overlooked by physicians.

Source: www.lef.org

See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Posted in Frontiers in Cardiology and Cardiovascular Disorders, HTN, Melatonin & Circadian Regulation, Pharmacotherapy of Cardiovascular Disease | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 1,254 other subscribers
Recent Posts
- Press Release for Five Bilingual BioMed e-Series January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
- Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software December 13, 2022
- Science Has A Systemic Problem, Not an Innovation Problem December 12, 2022
- Chemistry Nobelist Carolyn Bertozzi’s years at UC Berkeley October 24, 2022
- Technion #1 in Europe in Field of AI for 2nd Straight Year October 20, 2022
- Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners October 11, 2022
- The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells October 11, 2022
- Cancer Policy Related News from Washington DC and New NCI Appointments October 4, 2022
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: